Brukinsa ( Zanubrutinib): a Bruton s Tyrosine Kinase Inhibitor (BTKI) for chronic lymphocytic leukemia (CLL)

Date:

2024-08-26

Time:

5:30pm - 6:30pm

Venue:

online

Organising Institute:

St Teresa s Hospital, St Paul s Hospital

Speaker:

Dr. Vox Ting, MPH, PhD. Senior Medical Liasion, Beigene Hong Kong

Related CPE Activities:

Can Good Diabetes Care Prevent Osteoporosis and Fracture

Organising Institute:
Hong Kong Medical Association

11-Dec-2024

ASHP Midyear Clinical Meeting and Exhibition 2024

Organising Institute:
American Society of Health System Pharmacists

8-Dec-2024
to 12-Dec-2024

26th Annual Certificate Course on Respiratory Medicine

Organising Institute:
Division of Respiratory Medicine, Department of Medicine & Therapeutics, Faculty of Medicine, CUHK

29-Nov-2024

Advances in Paediatrics 2024 - Nephrology and Intensive Care Medicine

Organising Institute:
Department of Paediatrics, Chinese University of Hong Kong

23-Nov-2024
to 24-Nov-2024

The Asian Preventive Cardiology and Cardiac Rehabilitation Conference 2024

Organising Institute:
Hong Kong College of Cardiology

22-Nov-2024
to 24-Nov-2024